about
Naturally occurring systemic immune responses to HPV antigens do not predict regression of CIN2/3Aldehyde dehydrogenase expression drives human regulatory T cell resistance to posttransplantation cyclophosphamideHuman papillomavirus 16-associated cervical intraepithelial neoplasia in humans excludes CD8 T cells from dysplastic epitheliumAcute renal venous obstruction is more detrimental to the kidney than arterial occlusion: implication for murine models of acute kidney injuryPredictors of response to extracorporeal photopheresis in advanced mycosis fungoides and Sézary syndromeExpression of T-plastin, FoxP3 and other tumor-associated markers by leukemic T-cells of cutaneous T-cell lymphoma.Immunobiology and immunotherapeutic implications of syngeneic/autologous graft-versus-host disease.Autoimmune-mediated vasculopathy.Phenotypic analysis of prostate-infiltrating lymphocytes reveals TH17 and Treg skewingStereotactic Radiotherapy Increases Functionally Suppressive Regulatory T Cells in the Tumor Microenvironment.Detection and localization of surgically resectable cancers with a multi-analyte blood test.Chemokine receptor expression by leukemic T cells of cutaneous T-cell lymphoma: clinical and histopathological correlations.Antigen-specific T-lymphocyte responses in acute and chronic syngeneic graft-versus-host disease.Functional divergence of antigen-specific T-lymphocyte responses in syngeneic graft-versus-host disease.Functionally divergent T lymphocyte responses induced by modification of a self-peptide from a tumor-associated antigenThe combined use of elutriation and CD8/magnetic bead separation to engineer the bone marrow allograftBryostatin can induce antigen-specific nonresponsiveness in human peripheral blood T cellsSpecificity of effector T lymphocytes in autologous graft-versus-host disease: role of the major histocompatibility complex class II invariant chain peptideCharacterization of the V alpha/V beta autoreactive T-cell repertoire in syngeneic graft-vs-host diseaseSpecificity of effector mechanisms in syngeneic graft-vs-host disease: recognition of the MHC class II invariant chain peptide (CLIP)Unexpected T-cell diversity in syngeneic graft-versus-host disease revealed by interaction with peptide-loaded soluble MHC class II moleculesComplexity of effector mechanisms in cyclosporine-induced syngeneic graft-versus-host diseaseAutoreactive T-Cell subsets in acute and chronic syngeneic graft-versus-host diseasePromiscuous recognition of major histocompatibility complex class II determinants in cyclosporine-induced syngeneic graft-versus-host disease: specificity of cytolytic effector T cellsThe N-terminal flanking region of the invariant chain peptide augments the immunogenicity of a cryptic "self" epitope from a tumor-associated antigenPathogenic specificity of effector T lymphocytes in syngeneic graft-versus-host diseaseImmune tolerance to self-MHC class II antigens after bone marrow transplantationCharacterization of the pathogenic autoreactive T cells in cyclosporine-induced syngeneic graft-versus-host diseaseRegulation of OX40 gene expression in graft-versus-host diseaseImmune tolerance to self-major histocompatibility complex class II antigens after bone marrow transplantation: role of regulatory T cellsPilot trial of K562/GM-CSF whole-cell vaccination in MDS patientsA multimodality test to guide the management of patients with a pancreatic cyst
P50
Q34033800-61B4BD01-AEDF-4AFD-AACB-B0E3753BABE7Q34138598-58414A6C-85BA-47B8-ABD7-D8471ACBCF0CQ34788763-64D8B37F-DF87-48F1-8F99-09A133D67544Q35964466-524500F6-4F16-493A-8B04-10A32233A458Q36626781-00ABC0A8-BFEF-477B-9359-7BFD7FA155DDQ37698501-91E9F2C2-8F2B-4E22-B63C-4B4157FAC51DQ41561705-108A2174-8C4C-4486-B5F0-58607DF8FBCDQ41919486-749F2A5F-76FE-4D8C-9837-4773002150F7Q41953761-256615BF-7533-4DCA-BDEC-C535DBDAB080Q47880159-559AEF93-7431-467A-8311-EA2AE1BC2670Q48216212-938F9FC7-5B11-45BA-9448-060CEE760E66Q51974109-1012F258-56C7-4B44-83F7-80768A5B5061Q54672489-7E009DB5-7015-4369-A2CD-2244497FB7BDQ54705144-4D4EF429-0CBF-4F6A-BCD4-FAE7CC2677E5Q56902977-EFCABC12-6F4F-479A-B19F-5B90D41BF27AQ67937549-D5A394BF-45EF-4A8B-97D5-0116C5F08315Q72602615-4C89C3B5-0F2A-49C7-AC66-492B5D5EF6B0Q73128557-2377A5B6-123C-49EE-8376-D20936551D24Q73279427-43388789-AD50-40CD-BFF3-9C844087F665Q73279446-9AF0D375-4D4D-49D8-90F5-5A8DA89BFD5CQ73322581-B80CBDFA-5CED-416C-A0A2-2F39F751DD5BQ73523733-434FB37A-0BEB-4D17-98AE-089303CFA6C9Q73669435-39CC4972-D248-46DD-B944-B83CF6E7A8B5Q74432616-CD425DA8-072B-4D3C-8C61-494D04A95716Q74577913-535FAD23-684D-4C8E-848D-92F2E888CDF7Q74616601-94C65E4A-E349-4A5A-A2B8-FFE589C78860Q74616604-A5AEB49D-DB50-4F87-BBF5-F8F687D0C4E5Q77716181-43637FD3-58F9-4CB4-B90B-6B8411E5BF6DQ81610382-122FBAFD-101B-4659-B4E4-5E3E20D180BEQ83194681-EF47001B-E6FC-4342-96A3-9E943DEEF601Q88262690-6C840A2F-603D-4146-8060-F4B035B7705EQ91967661-9C61B9E7-8CE8-4359-829D-D567E8EE7655
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
ricercatore
@it
研究者
@zh
name
Christopher Thoburn
@en
Thoburn C
@ast
Thoburn C
@es
Thoburn C
@nl
type
label
Christopher Thoburn
@en
Thoburn C
@ast
Thoburn C
@es
Thoburn C
@nl
altLabel
Thoburn C
@en
prefLabel
Christopher Thoburn
@en
Thoburn C
@ast
Thoburn C
@es
Thoburn C
@nl
P31
P496
0000-0001-7743-9183